New York, NY -- (SBWIRE) -- 12/13/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Companhia Energetica Minas Gerais (ADR) (NYSE:CIG), Rexahn Pharmaceuticals, Inc (NYSEMKT:RNN), Standard Pacific Corp (NYSE:SPF), Dynavax Technologies Corporation(NASDAQ:DVAX)
Companhia Energetica Minas Gerais (ADR) (NYSE:CIG) showed a volume of 4.12 million shares by the end of last trade whereas the average volume of the stock remained 2.82 million shares. The stock opened the session at $7.94 but then moved to $7.88. At that price, the stock showed a positive performance of 1.93%. Companhia Energetica de Minas Gerais Cemig is a Brazil-based holding company primarily engaged in the electricity sector. The Company is mainly active in the construction and operation of systems of production, transformation, transmission, distribution and commercialization of electric power. It is involved in the provision of telecommunication services, and purchase, transport and distribution of natural gas. It has a number of subsidiaries, including Cemig Geracao e Transmissao, which operates hydroelectric plants,
Will CIG Continue To Move Higher? Find Out Here
Rexahn Pharmaceuticals, Inc (NYSEMKT:RNN) opened the session at $0.50 and closed the session at $0.276. The stock showed a negative performance of -9.37% in previous trading session. Traded with volume of 4.10 million shares in the prior session and the average volume of the stock remained 1.18 million shares. Rexahn Pharmaceuticals, Inc. (Rexahn) is a development-stage biopharmaceutical company. The Company focuses on the development of cures for cancer to patients worldwide. The Company’s pipeline features one drug candidate in Phase II clinical trials. The Company also has several other drug candidates in pre-clinical development. In addition, the Company has two renal cell carcinoma (CNS) candidates,
Has RNN Found The Bottom And Ready To Gain Momentum? Find Out Here
Standard Pacific Corp (NYSE:SPF) opened the session at $7.97 and closed the session at $8.01. The stock showed a positive performance of 0.38% in previous trading session. Traded with volume of 4.08 million shares in the prior session and the average volume of the stock remained 4.10 million shares. The beta of the stock remained 3.06. Standard Pacific Corp. is a geographically diversified business spans many of the housing markets, including metropolitan markets in California, Florida, the Carolinas, Texas, Arizona, and Colorado. The Company operates in two principal businesses: homebuilding and financial services (consisting of its mortgage financing and title operations).
Why Should Investors Buy SPF After The Recent Gain? Just Go Here and Find Out
Dynavax Technologies Corporation(NASDAQ:DVAX) the stock advanced 1.83% and finished the session at $1.67. Traded with volume of 4.09million shares in the prior session and the average volume of the stock remained 5.04 million shares. The beta of the stock remained 2.75. Dynavax Technologies Corporation (Dynavax) is a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases. Its product candidate is HEPLISAV, a Phase 3 investigational adult hepatitis B vaccine designed to provide higher and earlier protection with fewer doses than licensed vaccines. The Company’s pipeline of product candidates includes HEPLISAV,
Will DVAX Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)